API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.globenewswire.com/news-release/2024/04/12/2862377/0/en/Aquestive-Therapeutics-to-Present-Crossover-Study-Data-for-Libervant-diazepam-Buccal-Film-at-76th-Annual-Meeting-of-the-American-Academy-of-Neurology.html
https://www.prnewswire.com/news-releases/neurelis-announces-two-poster-presentations-at-the-76th-annual-meeting-of-the-american-academy-of-neurology-302112871.html
https://www.prnewswire.com/news-releases/neurelis-secures-new-orange-book-listed-us-patent-for-valtoco-diazepam-nasal-spray-civ-301994890.html
https://www.prnewswire.com/news-releases/aculys-pharma-delivers-positive-phase-3-clinical-study-interim-analysis-result-of-a-diazepam-nasal-spray-an-antiepileptic-drug-for-the-treatment-of-epileptic-seizures-301959812.html
https://www.prnewswire.com/news-releases/neurelis-to-present-analyses-of-valtoco-diazepam-nasal-spray-civ-at-the-52nd-child-neurology-society-annual-meeting-301946700.html
https://www.globenewswire.com//news-release/2023/09/11/2740761/0/en/Aquestive-Therapeutics-Receives-FDA-Acceptance-of-New-Drug-Application-NDA-for-Libervant-diazepam-Buccal-Film-in-Pediatric-Patients-and-Assignment-of-Prescription-Drug-User-Fee-Act.html
https://www.prnewswire.com/news-releases/neurelis-to-present-analyses-of-valtoco-diazepam-nasal-spray-civ-highlighting-effects-on-timing-of-seizures-at-the-35th-international-epilepsy-congress-301914197.html
https://www.globenewswire.com/news-release/2023/06/29/2697011/0/en/Aquestive-Therapeutics-Provides-Business-Update-and-Announces-Chief-Medical-Officer-Appointment.html
https://www.cnbctv18.com/healthcare/lupin-gets-us-fda-approval-for-diazepam-rectal-gel-16828051.htm
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091076
https://www.contractpharma.com/contents/view_breaking-news/2023-03-29/thermo-fisher-arsenal-biosciences-partner-to-manufacture-autologous-t-cell-therapies/?widget=listSection
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214745
https://www.biospace.com/article/releases/neurelis-presents-novel-investigational-analysis-of-valtoco-diazepam-nasal-spray-civ-demonstrating-increased-time-between-seizure-clusters-at-the-51st-child-neurology-society-annual-meeting/
https://www.prnewswire.com/news-releases/neurelis-presents-novel-investigational-analysis-of-valtoco-diazepam-nasal-spray-civ-demonstrating-increased-time-between-seizure-clusters-at-the-51st-child-neurology-society-annual-meeting-301648514.html
https://www.prnewswire.com/news-releases/neurelis-announces-presentation-of-analysis-of-time-between-seizure-clusters-with-valtoco-diazepam-nasal-spray-civ-at-the-2022-annual-meeting-of-the-academy-of-managed-care-pharmacy-301647078.html
https://www.globenewswire.com/news-release/2022/09/28/2524267/0/en/Aquestive-Therapeutics-Enters-License-and-Supply-Agreement-with-Pharmanovia-for-Libervant-diazepam-Buccal-Film-for-European-and-MENA-Markets.html
https://www.prnewswire.com/news-releases/study-published-in-epilepsia-shows-significant-prolongation-of-time-intervals-between-seizure-clusters-treated-with-neurelis-valtoco-diazepam-nasal-spray-civ-301618926.html
https://aquestive.com/aquestive-therapeutics-receives-fda-tentative-approval-for-libervant-diazepam-buccal-film/
https://www.prnewswire.com/news-releases/new-quality-of-life-data-for-valtoco-diazepam-nasal-spray-civ-in-the-treatment-of-seizure-clusters-published-in-epilepsy--behavior-301589677.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-23-2022-1645600799.pdf
https://www.prnewswire.com/news-releases/neurelis-signs-exclusive-licensing-agreement-with-aculys-pharma-for-the-development-and-commercialization-of-valtoco-diazepam-nasal-spray-in-japan-and-the-asia-pacific-region-301465612.html
https://psnc.org.uk/our-news/supply-disruption-alert-diazepam-rectubes-2-5mg-rectal-solution-wockhardt-uk-ltd/
https://www.globenewswire.com/news-release/2021/06/24/2252522/0/en/Aquestive-Therapeutics-Resubmits-New-Drug-Application-for-Libervant-diazepam-Buccal-Film.html
https://www.prnewswire.com/news-releases/neurelis-announces-national-wholesale-and-retailer-chains-and-independent-pharmacies-are-now-stocking-valtoco-diazepam-nasal-spray-301168387.html
https://www.biospace.com/article/releases/xeris-pharmaceuticals-granted-fast-track-designation-by-the-fda-for-its-novel-concentrated-diazepam-formulation-xp-0863-for-injection-/
https://www.prnewswire.com/news-releases/neurelis-announces-fda-approval-of-extended-expiration-dating-for-valtoco-diazepam-nasal-spray-301154566.html
https://www.prnewswire.com/news-releases/neurelis-announces-four-poster-presentations-for-the-joint-meeting-of-the-international-child-neurology-association-and-child-neurology-society-301153844.html
https://seekingalpha.com/pr/18020829-aquestive-therapeutics-receives-complete-response-letter-from-fda-for-libervant-diazepam
https://www.prnewswire.com/news-releases/neurelis-announces-rapid-and-broad-payer-coverage-of-the-companys-flagship-product-valtoco-diazepam-nasal-spray-301071681.html
https://www.prnewswire.com/news-releases/neurelis-announces-total-of-nine-poster-presentations-for-the-aann-amcp-and-aan-annual-meetings-301062493.html
https://www.biospace.com/article/releases/xeris-pharmaceuticals-announces-positive-topline-results-from-a-study-of-its-novel-formulation-of-diazepam-injection/
https://endpts.com/clinical-superiority-diszepam-nasal-spray-illustrates-fda-parameters-for-orphan-drug-exclusivity/
https://www.raps.org/news-and-articles/news-articles/2020/1/clinical-superiority-fda-finds-diazepam-nasal-s
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211998
http://www.pharmafile.com/news/535059/seizures-black-market-diazepam-tablets-double-uk-year
https://seekingalpha.com/news/3501907-emergent-bio-nabs-20m-dod-develop-diazepam-auto-injector
https://www.fiercepharma.com/marketing/neurelis-debuts-seizure-awareness-campaign-as-it-waits-fda-nod-for-nasal-spray-for
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210363
https://www.npr.org/sections/health-shots/2019/01/25/688287824/steep-climb-in-benzodiazepine-prescribing-by-primary-care-doctors
https://www.prnewswire.com/news-releases/aquestive-therapeutics-provides-end-of-year-business-update-including-progress-of-its-proprietary-cns-assets-financial-and-legal-matters-300769525.html
https://health.economictimes.indiatimes.com/news/pharma/ncb-busts-gurgaon-based-online-pharmacy-for-shipping-illegal-drugs/65271399
https://www.fiercepharma.com/pharma/nebraska-lawmaker-urges-pfizer-to-sue-over-lethal-injection-procedure
https://www.in-pharmatechnologist.com/Article/2017/11/21/Pfizer-demands-return-of-drugs-set-for-use-in-US-lethal-injections
https://www.fiercepharma.com/pharma/pfizer-fight-states-over-their-intent-to-use-its-drugs-for-executions
http://www.thestate.com/news/business/national-business/article185170433.html
http://www.smh.com.au/national/health/second-valium-manufacturer--arrow-recalls-medication-after-fears-of-tampering-at-sydney-factory-20170609-gwoklh.html
http://www.fiercepharma.com/manufacturing/roche-recalls-valium-australia-after-tampering-uncovered
https://www.pharmacompass.com/pdf/news/roche-recalls-all-batches-of-valium-diazepam-5-mg-tablets-in-50-tablet-blister-packs-due-to-medicine-tampering-1495873294.pdf
https://globenewswire.com/news-release/2017/01/24/910367/0/en/MonoSol-Rx-Appoints-John-T-Maxwell-as-Chief-Financial-Officer.html